Locus Coeruleus and Sleep Disturbances in Preclinical Alzheimer’s Disease

Principal Investigator

Project Goals

To determine if modifications in the structure and function of the LC relate to changes in the sleep-wake cycle, in the accumulation of hallmark AD pathologies, and ultimately to cognitive decline. First, multi-modal 7T MRI assessments of the LC will be related to sleep-wake fragmentation metrics derived from actigraphic recordings to examine the links between LC structural/functional properties and sleep-wake regulation in cognitively unimpaired adults. Then, the impact of APOE status and plasma AD biomarkers on the relationship between LC integrity and sleep-wake regulation will be assessed. Finally, the predictive value of these variables for AD-related cognitive decline will be evaluated based on longitudinal assessments of cognition over three years.

Project Summary

So far, researchers who aimed to link LC properties to sleep-wake regulation measures in humans were confronted by the extreme difficulty to image this nucleus in vivo, due to its deep location in the brainstem and its small size. Our proposal takes advantage of state-of-the-art methods in ultra-high field neuroimaging to extensively characterize the LC in vivo with unprecedented resolution. This will allow, for the first time, to address the existing gap in the understanding of the interplay between LC alterations, sleep-wake patterns, and AD-related pathophysiological processes in humans. The outcomes of this project will contribute to disentangling the intricate relationships between LC integrity, sleep-wake regulation, and AD-related processes, which will provide crucial information about the mechanisms at play in the earliest stages of the disease. As sleep deprivation is a trademark of our 24/7 society, this study will provide researchers and clinicians with new, early targets, and will pave the way toward novel treatments based on implementing preventive interventions in individuals who have been identified at higher risk of developing AD.

First published on: November 08, 2021

Last modified on: June 24, 2024